BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8597129)

  • 21. Non-genotoxic mechanisms of carcinogenesis: studies of cell transformation and gap junctional intercellular communication.
    Yamasaki H
    Toxicol Lett; 1995 May; 77(1-3):55-61. PubMed ID: 7618169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gap junctions: basic structure and function.
    Meşe G; Richard G; White TW
    J Invest Dermatol; 2007 Nov; 127(11):2516-24. PubMed ID: 17934503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Connexin genes and cell growth control.
    Yamasaki H; Krutovskikh V; Mesnil M; Omori Y
    Arch Toxicol Suppl; 1996; 18():105-14. PubMed ID: 8678786
    [No Abstract]   [Full Text] [Related]  

  • 24. Epigenetic properties of the diarrhetic marine toxin okadaic acid: inhibition of the gap junctional intercellular communication in a human intestine epithelial cell line.
    Traoré A; Baudrimont I; Dano S; Sanni A; Larondelle Y; Schneider YJ; Creppy EE
    Arch Toxicol; 2003 Nov; 77(11):657-62. PubMed ID: 14504690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of gap junctions in tumor suppression: analysis of genetically-manipulated mice.
    Omori Y; Zaidan Dagli ML; Yamakage K; Yamasaki H
    Mutat Res; 2001 Jun; 477(1-2):191-6. PubMed ID: 11376700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective gap junctional intercellular communication in the carcinogenic process.
    Mesnil M; Crespin S; Avanzo JL; Zaidan-Dagli ML
    Biochim Biophys Acta; 2005 Dec; 1719(1-2):125-45. PubMed ID: 16359943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects.
    Omori Y; Mesnil M; Yamasaki H
    Mol Biol Cell; 1996 Jun; 7(6):907-16. PubMed ID: 8816997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gap junctions and cancer: communicating for 50 years.
    Aasen T; Mesnil M; Naus CC; Lampe PD; Laird DW
    Nat Rev Cancer; 2016 Dec; 16(12):775-788. PubMed ID: 27782134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Connexin mimetic peptides: specific inhibitors of gap-junctional intercellular communication.
    Evans WH; Boitano S
    Biochem Soc Trans; 2001 Aug; 29(Pt 4):606-12. PubMed ID: 11498037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of intercellular communication via "gap junctions" in disease].
    Vinken M; Vanhaecke T; Rogiers V
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2463-6. PubMed ID: 14708210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional significance of gap junctional coupling in preimplantation development.
    Houghton FD; Barr KJ; Walter G; Gabriel HD; Grümmer R; Traub O; Leese HJ; Winterhager E; Kidder GM
    Biol Reprod; 2002 May; 66(5):1403-12. PubMed ID: 11967204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of the defect in gap-junctional communication by expression of a connexin 26 mutant associated with dominant deafness.
    Chen Y; Deng Y; Bao X; Reuss L; Altenberg GA
    FASEB J; 2005 Sep; 19(11):1516-8. PubMed ID: 16009703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the gap junctional intercellular communication in renal tubular epithelial cells in vitro treated with renal carcinogens.
    Noguchi M; Nomata K; Watanabe J; Kanetake H; Saito Y
    Cancer Lett; 1998 Jan; 122(1-2):77-84. PubMed ID: 9464494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of connexins by the ubiquitin system: Implications for intercellular communication and cancer.
    Leithe E
    Biochim Biophys Acta; 2016 Apr; 1865(2):133-46. PubMed ID: 26855059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32.
    Krutovskikh V; Mazzoleni G; Mironov N; Omori Y; Aguelon AM; Mesnil M; Berger F; Partensky C; Yamasaki H
    Int J Cancer; 1994 Jan; 56(1):87-94. PubMed ID: 8262683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gap junctions and connexins as therapeutic targets in cancer.
    Kandouz M; Batist G
    Expert Opin Ther Targets; 2010 Jul; 14(7):681-92. PubMed ID: 20446866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intercellular communication in the eye: clarifying the need for connexin diversity.
    White TW; Bruzzone R
    Brain Res Brain Res Rev; 2000 Apr; 32(1):130-7. PubMed ID: 10751662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gap junction channels: new roles in disease.
    Donaldson P; Eckert R; Green C; Kistler J
    Histol Histopathol; 1997 Jan; 12(1):219-31. PubMed ID: 9046057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mimetic peptides as blockers of connexin channel-facilitated intercellular communication.
    Evans WH; Leybaert L
    Cell Commun Adhes; 2007; 14(6):265-73. PubMed ID: 18392994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of up-regulated gap junctional intercellular communication during chemoprevention and chemotherapy of cancer.
    Trosko JE; Chang CC
    Mutat Res; 2001 Sep; 480-481():219-29. PubMed ID: 11506816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.